Pharma stocks drag stock markets lower after Trump's 100% drug tariff threat

Dr. VK Vijayakumar, Chief Investment Strategist at Geojit Investments Limited, said, "President Trump's tantrums with tariffs are resuming with new tariff imposts on patented and branded drugs. India being an exporter of generic drugs is unlikely to be impacted by this. But perhaps the president's next target can be the generic drugs. This decision may have a sentimental impact on pharmaceutical stocks."